Estradiol modulates the sodium pump in the heart sarcolemma

被引:30
作者
Dzurba, A
Ziegelhoffer, A
Vrbjar, N
Styk, J
Slezak, J
机构
[1] Institute for Heart Research, Slovak Academy of Sciences, Dúbravská cesta 9
关键词
estradiol; heart sarcolemma; Na; K-ATPase; protection of the heart;
D O I
10.1023/A:1006835214312
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiovascular effects of estrogens and particularly that of estradiol involve protection of the heart against ischemia. These effects were believed to be mainly indirect, mediated via changes in the blood and blood vessels. In the present paper a direct action of estradiol on the heart is demonstrated. Estradiol stimulates (p < 0.001) the Na,K-ATPase activity of cardiac sarcolemmal membranes by stimulating in an allosteric manner, the activation of the enzyme by potassium. The latter activation involves also an increase in affinity to potassium of the potassium binding sites on the enzyme molecule, but remains without any effect on the capacity and K-D value of specific ouabain binding to the Na,K-ATPase. Estradiol is also antagonizing the depression of Na,K-ATPase activity that may be caused by ischemia and it is stimulating (p < 0.01) the ouabain-sensitive uptake of Rb-86 into the heart cells. Our results indicate, that in addition to the known indirect effects of estradiol on the heart, the hormone also stimulates the activity and improves the kinetics of interaction of cardiac sarcolemmal Na,K-ATPase with ATP as well as with Na+ and K+ ions. This direct action may also account for the cardioprotective effects of estradiol.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 22 条
[1]   ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN [J].
BARRETTCONNOR, E ;
BUSH, TL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14) :1861-1867
[2]  
BARTA E, 1989, PHYSIOL BOHEMOSLOV, V38, P193
[3]   CARDIOVASCULAR MORTALITY AND NONCONTRACEPTIVE USE OF ESTROGEN IN WOMEN - RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J].
BUSH, TL ;
BARRETTCONNOR, E ;
COWAN, LD ;
CRIQUI, MH ;
WALLACE, RB ;
SUCHINDRAN, CM ;
TYROLER, HA ;
RIFKIND, BM .
CIRCULATION, 1987, 75 (06) :1102-1109
[4]  
CASTELLI WP, 1982, WIEN MED WCHSCHR BEI, V2, P1
[5]   MENOPAUSE AND THE RISK OF CORONARY HEART-DISEASE IN WOMEN [J].
COLDITZ, GA ;
WILLETT, WC ;
STAMPFER, MJ ;
ROSNER, B ;
SPEIZER, FE ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (18) :1105-1110
[6]   NITRIC-OXIDE ACCOUNTS FOR DOSE-DEPENDENT ESTROGEN-MEDIATED CORONARY RELAXATION AFTER ACUTE ESTROGEN WITHDRAWAL [J].
COLLINS, P ;
SHAY, J ;
JIANG, CW ;
MOSS, J .
CIRCULATION, 1994, 90 (04) :1964-1968
[7]  
DZURBA A, 1983, P INT S HORM CARD SY, P21
[8]   The vascular protective effects of estrogen [J].
Farhat, MY ;
Lavigne, MC ;
Ramwell, PW .
FASEB JOURNAL, 1996, 10 (05) :615-624
[9]   STUDIES ON MECHANISM OF DOG HEART (NA++K+)-ATPASE INHIBITION BY D,L-ASPARTIC ACID AND ITS K+ AND MG2+ SALTS [J].
FEDELESOVA, M ;
DZURBA, A ;
ZIEGELHOFFER, A .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (20) :1847-1850
[10]  
FRANCK D, 1984, BIOMED BIOCHIM ACTA, V43, pS91